FCER1A and anaphylaxis: Alternatively to anti-IgE molecules, a recent approach using anti-FcεRIα monoclonal antibodies strongly suppressed IgE-mediated MC activation in a humanized mouse model of food allergy and anaphylaxis, revealing another promising therapeutic option (169) (Table 3).